Therefore, given that anti-TNFSF10 treatment modulated miR-155 (Fig. 3A), we also investigated the effect of the TNFSF10 immunoneutralization on the expression of its molecular target SOCS-1 in the retinas of the same AD animals. This evidence concerns the gene SOCS1 and Alzheimer disease.